---
title: "10 drugs have been suspended from procurement qualifications, involving Staidson BioPharm, Baillie Pharmaceutical, and other companies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257665320.md"
description: "According to the Shanghai Sunshine Pharmaceutical Procurement Network news on September 15, the Shanghai Municipal Pharmaceutical Centralized Bidding Procurement Affairs Management Office issued a notice stating that, in accordance with relevant documents from the National Healthcare Security Administration, due to some companies failing to adjust drug prices as required, the procurement qualifications for certain drugs will be suspended starting from 0:00 on September 16, 2025. A total of 10 drugs, including 15 specifications, will have their procurement qualifications suspended, involving 11 companies such as Staidson BioPharm and Sichuan Baile Pharmaceutical Co., Ltd"
datetime: "2025-09-17T06:59:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257665320.md)
  - [en](https://longbridge.com/en/news/257665320.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257665320.md)
---

# 10 drugs have been suspended from procurement qualifications, involving Staidson BioPharm, Baillie Pharmaceutical, and other companies

According to news from the Shanghai Sunshine Pharmaceutical Procurement Network on September 15, the Shanghai Municipal Pharmaceutical Centralized Bidding Procurement Affairs Management Office issued a notice stating that, according to relevant documents from the National Healthcare Security Administration, due to some companies failing to adjust drug prices as required, the procurement qualifications for certain drugs will be suspended starting from 0:00 on September 16, 2025. A total of 10 drugs, including 15 specifications, are affected, involving 11 companies such as Staidson BioPharm and Sichuan Baile Pharmaceutical Co., Ltd

### Related Stocks

- [300204.CN](https://longbridge.com/en/quote/300204.CN.md)

## Related News & Research

- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [Mattel is Searching for the First Hot Wheels Tiniest Team Principal | MAT Stock News](https://longbridge.com/en/news/286957208.md)
- [God of War’s bold new spinoff stars Faye: will it work?](https://longbridge.com/en/news/286908907.md)
- [RUBBER-Japan futures extend gains on weaker yen, tight Thai supply](https://longbridge.com/en/news/286840226.md)
- [ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth](https://longbridge.com/en/news/286928593.md)